Drugmaker

A dose of MDMA. The drug has been studied as a treatment for PTSD and FDA has declined to approve…

Key Takeaways Eli Lilly is partnering with ChatGPT maker OpenAI to use artificial intelligence to develop new treatments to combat…

Enlarge / Lars Fruergaard Jorgensen, chief executive officer Novo Nordisk A/S, during an interview at the company’s headquarters in Bagsvaerd,…